long term use of glp 1 Do You Have To Keep Taking GLP‑1 Forever? Real‑Life Outcomes & Choices In 2026 The unknown trajectory of GLP-1

Within this context, Lillys meticulous R&D strategy and market execution have paid off: Mounjaro and ZepBound are generating record sales, and Lillys pipeline is deep with next-generation incretin candidates

Sitagliptin added to ongoing metformin therapy provides sustained glycemic control over 54 weeks, with a low incidence of hypoglycemia and with weight loss (Abstract 0523-P)

In one study , 1,961 adults with obesity or overweight plus at least one weight-related medical condition regained two-thirds of the weight they had lost within one year of stopping semaglutide treatment and lifestyle interventions

Sima E, Webb DL, Hellstrm PM, Sundbom M